Journal
JOURNAL OF SCLERODERMA AND RELATED DISORDERS
Volume 7, Issue 2, Pages 85-97Publisher
SAGE PUBLICATIONS LTD
DOI: 10.1177/23971983221086343
Keywords
Systemic sclerosis; scleroderma complications; gastrointestinal; SSc-related gastrointestinal disease; management; GI complications; dysmotility
Categories
Funding
- NIH/NIAMS [K23 AR071473]
- Rheumatology Research Foundation
- [K24 AR063120-06A1]
Ask authors/readers for more resources
Gastrointestinal symptoms are common in patients with systemic sclerosis, and managing these complications can be challenging due to the variability in clinical presentation. New findings related to the management of systemic sclerosis-related gastrointestinal disease are highlighted, with areas for further elucidation still remaining.
Gastrointestinal symptoms affect the great majority of patients with systemic sclerosis. Management of these complications is often challenging as any region of the gastrointestinal tract may be involved, and significant heterogeneity exists in clinical presentation, kinetics, and outcomes. Here, we highlight new findings relevant to the management of systemic sclerosis-related gastrointestinal disease (lights) and consider areas that we have yet to elucidate (shadows).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available